VACCINE RISK
Bengaluru witnessing sharp rise in dengue cases: Doctors say situation may worsen, women and children at greater risk
Hospitals in Bengaluru report a sharp rise in dengue cases, especially among women and children, with 60 new cases daily according to BBMP data. Pregnant women face increased risks, including hemorrhagic fever and complications for the fetus. Medical experts advise strict preventive measures, such as avoiding water stagnation and using mosquito repellents, to mitigate the spread of the disease.
This new genetic trait can be the key Alzheimer's cure? Here's what we know
Alzheimer's is a very common disease that plagues thousands of Americans in their prime. However, researchers have now stumbled upon a very new kind of genetic trait that can delay the effects of Alzheimer's, according to recent reports. An extended family based in Colombia's Medellin, was analyzed upon, to derive these results.
Bharat Bio's Rotavirus vaccine Rotavac may be unsafe for children: Study
A study found that Bharat Biotech's Rotavac vaccine used in the government's immunization program increases the risk of intussusception in infants, a condition where the intestine telescopes into itself, leading to potential serious consequences.
‘Doctors knew Covid vaccine’s side-effects killed my daughter. But they didn’t tell us’
Dr Snehal Lunawat was the first case in which the AEFI committee accepted there was a direct correlation between vaccination and death. Many of the petitioners, like her father Dilip, have questioned why information about the side-effects wasn’t made public earlier.
Staying with good business & strong management: 5 largecap stocks from different sectors with upside potential of up to 37%
After a phase of calm, volatility is back on the street. Somehow word volatility got associated with bearish trend, while it might appear strange to some, the fact is that even volatility has a bias and that can be toward bulls also. That is the reason why in this volatile phase, Nifty made a new high. So, rather than fearing a word it is better to understand it. Similarly when it comes to investing, it is important to understand that while events can impact the price in the short term. In the long term, things which matter is the underlying business, strength and quality of the balance sheet, ability and experience of the management. Whether it is pre-election or post election, always have a look at the above three when investing your hard earned money.
As COVID cases rise again, what do you need to know about the new FLiRT variants?
FLirt Covid 19 Virus: Scientists are studying the FLiRT variants, subvariants of the Omicron lineage, which may be more contagious and evade immunity better. The FLiRT variants, derived from the JN.1 variant, are demonstrating increased 'fitness' and may become the dominant subvariants in Australia. Booster shots targeting Omicron XBB.1.5 provide significant protection against severe illness.
HPV vaccines may protect men as well as women from cancer claims new study
Vaccinated women had a lower risk of developing cervical cancer within at least five years of getting the shots. For men, there were benefits too. Vaccinated men had a lower risk of developing any HPV-related cancer, such as cancers of the anus, penis and mouth and throat.
Stock picks of the week: 4 stocks with consistent score improvement and upside potential of up to 29 %
It is after a long period of time that both bulls and bears are visible on the street at the same time and waiting to make the next move. A strong directional move will only come after election results. Before that it is very likely that the market would stay in range bound mode. During this period it would be better to stay with selected stocks, have at your portfolio and do a rejig with focus on fundamentals of the sector and the stocks. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
Covaxin demonstrated excellent safety record during studies: Bharat Biotech
Bharat Biotech asserted the safety of its Covid-19 vaccine, Covaxin, citing various studies published in peer-reviewed journals. This statement followed a report in The Economic Times regarding adverse events of special interest (AESI) reported by participants in an observational study on Covaxin. The company emphasized the need for comprehensive safety data in such studies, including comparisons with non-vaccinated subjects and those receiving other vaccines.
Covaxin, Covishield alert: Scammers exploiting vaccine fears, police issue alert
Authorities are alarmed by a surge in fraudulent activities exploiting Covid-19 vaccine inquiries, targeting unsuspecting individuals for personal information. Scammers, posing as health officials, prompt citizens for Covishield or Covaxin details, aiming to harvest sensitive data. Kolkata residents report such incidents, including calls from interactive voice systems causing network disruptions.
Covaxin side effects: What are the symptoms reported in adverse event cases? Should you worry?
Covaxin side effects: A recent study highlighted adverse events post-Bharat Biotech's Covaxin vaccinations. Led by Sankha Shubhra Chakrabarti, it noted higher risk in female adolescents and those with allergies. Of 1,024 participants, 47.9% adolescents and 42.6% adults reported viral infections. Common AESIs included skin disorders, menstrual abnormalities in females, and serious cases like stroke. Monitoring vaccinated individuals, especially those with prior Covid history, is crucial.
Adverse events seen in some participants who took Covaxin, reports new study
Covaxin Vaccine Side Effects: In an observational study on Bharat Biotech's Covaxin, nearly a third of participants reported adverse events of special interest (AESI), with females and those with allergies at higher risk. The majority of AESIs persisted at the 1-year follow-up. Common AESIs included viral upper respiratory tract infections, skin disorders, and nervous system issues. Serious AESIs like stroke and Guillain-Barre Syndrome were rare but reported. Females, adolescents, and those with pre-vaccination Covid-19 or comorbidities had higher odds of AESIs. Extended surveillance is recommended to understand late-onset adverse events.
Good shot, bad shot: What you need to know about Covishield issue
Covishield Side Effects: Controversies surrounding vaccine side-effects persist despite Covid-19 waning. Covishield, developed by AstraZeneca and Oxford University, faces scrutiny in India following reports of rare side effects. Legal battles and demands for compensation have emerged as families of alleged victims seek justice. Experts stress the importance of understanding risks versus benefits in vaccine administration.
BJP has put lives of its countrymen at risk: SP chief Akhilesh Yadav on global withdrawal of Covishield
Akhilesh Yadav slams BJP for risking lives with AstraZeneca's global Covishield withdrawal due to excess supply. How will dangerous vaccine return from recipients? Rare side effect TTS disclosed.
Nearly 12 pc of India's eligible children received no dose of measles vaccine, study finds
Researchers from the Ministry of Health and Family Welfare and Banaras Hindu University in Varanasi investigated previously overlooked critical aspects of measles vaccination, focusing on zero-doses, partially vaccinated, and those fully immunised. They analysed data of over 43,000 children aged 2-3 years, collected through the National Family Health Survey 2019-21 (NFHS-5).
Worrying vaccination gaps come to notice after post-Covid measles spurt forces a data relook
A relook at the survey data was necessitated by instances of repeated measles outbreaks after the COVID-19 pandemic, the report by (by Rema Nagarajan) said.
Every vaccine carries a risk. If benefits outweigh it, you use it: Dr Shahid Jameel
In India, where the majority of people were administered Covishield the news of a lawsuit against AstraZeneca in the UK over Covid vaccination has caused concern. Dr Shahid Jameel, virologist and research fellow at Green Templeton College,University of Oxford, tells Indulekha Aravind that there is no cause for worry as benefits far outweigh risks.
Amid Covishield row, what WHO says on side-effects from Covid vaccine? Should you be worried?
Recent revelations by pharmaceutical company AstraZeneca have brought Covid vaccines back into the spotlight, with acknowledgment that its AstraZeneca-Oxford vaccine can, in very rare instances, lead to Thrombosis Thrombocytopenia Syndrome (TTS)," a condition involving the formation of blood clots in blood vessels. Despite these rare occurrences, the pharmaceutical firm maintains that extensive clinical trial data and real-world evidence consistently support the safety and effectiveness of the vaccine.
BJP put lives at stake for extorting political donations from vaccine manufacturer: Akhilesh Yadav
Amid a controversy surrounding the Covishield vaccine's alleged side effects, Samajwadi Party chief Akhilesh Yadav accused the BJP of risking lives for political donations from the vaccine manufacturer. He called for a high-level judicial probe, stating that allowing such medicines is akin to a conspiracy to commit murder. AstraZeneca, the manufacturer of Covishield, has admitted to a rare blood clot-related side effect in its COVID-19 vaccine. Akhilesh Yadav criticised the BJP for allegedly putting public lives at risk for political gain and called for a thorough investigation into the matter. The controversy has sparked concerns about the safety and efficacy of the vaccine, with opposition leaders demanding accountability and transparency in vaccine distribution.
Load More
